Researchers at Harvard Medical School have sequenced the genomes of a family in which multiple members had pancreatic cancer and found a mutation in a gene linked to the RAS signaling pathway that controls cell growth and death. Researchers argue that the into how RABL3 impacts the signaling pathway could lead to novel targeted therapy.
Thrive said its goal is to incorporate CancerSEEK into routine medical care, where it can detect more cancers at earlier stages.
The coronavirus pandemic compels diagnostics companies to bring new assays, technologies to market.
The American College of Medical Genetics and Genomics (ACMG) said today it will establish a program designed to develop new evidence-based guidelines in medical...
Postdocs working in the lab of Jennifer Doudna at UC Berkeley bring the testing lab online in just three weeks.
The antibody test is based on the receptor-binding domain (RBD) of the spike protein. The RBD-based antibody test measures the levels of that domain, which the authors found correlate to the levels of neutralizing antibodies.
Findings from the new study could point to methods for identifying diseases and predicting their behaviors that are faster, simpler, less expensive, and more accurate than current standard techniques.
Molecular diagnostics providers seek ways to maintain services in a world consumed by COVID-19.
GeneDx will develop assays targeting muscular dystrophies, developmental, and reproductive disorders using Saphyr, which detects CNVs, FSHD repeat contractions, repeat expansions, balanced and unbalanced translocations, and other complex rearrangements.
The companies will co-commercialize their respective single-cell technologies for CTCs and PD-L1 expression following positive study results